Dopamine D2 Receptor Antagonists

All categories
DBCAT000879Therapeutic category

Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS. A DrugBank category of 66 drugs. 49 of them are approved.

Part of
Dopamine Antagonists
Also known as
Antagonists, Dopamine D2 · D2 Antagonists, Dopamine · Dopamine D2 Antagonists · Dopamine-2 Receptor Antagonist · Receptor Antagonists, Dopamine D2
Drugs

and 41 more with a free account

What you can answer from here — as of June 07, 2018

66DrugsEach linked to its full drug card
Sign in
95Drug targetsEvery drug–target pair in the class, with bond type
Sign in
20,381Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
16Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Dopamine D2 Receptor Antagonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In